APA

Tong X. W., Engehausen D. G., Kaufman R. H., Agoulnik I., Contant C., Freund C. T., Oehler M. K., Kim T. E., Hasenburg A., Woo S. L. & Kieback D. G. (19980618). Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy. : Anticancer research.

Chicago

Tong X W, Engehausen D G, Kaufman R H, Agoulnik I, Contant C, Freund C T, Oehler M K, Kim T E, Hasenburg A, Woo S L and Kieback D G. 19980618. Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy. : Anticancer research.

Harvard

Tong X. W., Engehausen D. G., Kaufman R. H., Agoulnik I., Contant C., Freund C. T., Oehler M. K., Kim T. E., Hasenburg A., Woo S. L. and Kieback D. G. (19980618). Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy. : Anticancer research.

MLA

Tong X W, Engehausen D G, Kaufman R H, Agoulnik I, Contant C, Freund C T, Oehler M K, Kim T E, Hasenburg A, Woo S L and Kieback D G. Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy. : Anticancer research. 19980618.